Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag and Diacerein in eltrombopag-inefficient or relapsed ITP
NCT03754634Phase 2Completed
- Sponsor
- Shandong University
- Start
- May 2019
- Primary completion
- Jun 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of diacerein in immune thrombocytopenia (ITP), sponsored by Shandong University. Started May 2019; status: completed.
02
Drugs
diacerein
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03754634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754634.